ANI Pharmaceuticals ANIP Gross margin

Gross margin at other companies

Amneal Pharmaceuticals, Inc.AMRX

39.3%+1.7pp

ViatrisVTRS

34.8%-1.8pp

ALN

Alnylam PharmaceuticalsALNY

79.8%-4.1pp

Eton Pharmaceuticals, Inc.ETON

54.8%-3.7pp

Aurinia PharmaceuticalsAUPH

90.4%+0.8pp

Zevra Therapeutics, Inc.ZVRA

95.5%+23.5pp

FAQ

What is ANI Pharmaceuticals's gross margin?

ANI Pharmaceuticals (ANIP) reported gross margin of 60.4% in Q2 2026.

How has ANI Pharmaceuticals's gross margin changed year-over-year?

ANI Pharmaceuticals's gross margin decreased by 1.1% year-over-year, from 61.1% to 60.4%.

What is the long-term trend for ANI Pharmaceuticals's gross margin?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's gross margin has grown at a 1.1% compound annual growth rate (CAGR), from 58.2% to 61.4%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.